Select Medical Holdings Corpora

Historical 13F Holders

Symbol
SEM
CUSIP
81619Q105
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 81619Q105 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 9.9% 7/30/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
Glazer Capital, LLC 13G/A
8.7%
Checked 5% or less
8/13/2026
Event 6/30/2026
Ortenzio Rocco A 13G/A 3.2% 1/30/2025
Event 12/31/2024
Price T Rowe Associates Inc /MD/ 13G/A 0.1% 4/8/2026
Event 3/31/2026
Vanguard Portfolio Management LLC 13G/A 0% 7/31/2026
Event 6/30/2026
Ortenzio Robert A 13D/A
0% 7/1/2026
Event 7/1/2026
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 1 1.06 k $17.5k
2026 Q2 242 91.2 M $1.60B
2026 Q1 278 98.1 M $1.60B
2025 Q4 270 101 M $1.51B
2025 Q3 268 101 M $1.30B
2025 Q2 264 101 M $1.53B
2025 Q1 276 108 M $1.81B
2024 Q4 272 106 M $1.99B
2024 Q3 290 99.8 M $3.48B
2024 Q2 258 101 M $3.54B
2024 Q1 252 102 M $3.09B
2023 Q4 250 100 M $2.36B
2023 Q3 250 97.3 M $2.46B
2023 Q2 228 99.3 M $3.15B
2023 Q1 218 103 M $2.67B
2022 Q4 215 107 M $2.65B
2022 Q3 217 102 M $2.25B
2022 Q2 218 100 M $2.37B
2022 Q1 242 104 M $2.49B
2021 Q4 245 103 M $3.04B
2021 Q3 254 104 M $3.76B
2021 Q2 267 105 M $4.43B
2021 Q1 258 104 M $3.54B
2020 Q4 210 109 M $3.02B
2020 Q3 199 102 M $2.12B
2020 Q2 205 103 M $1.52B
2020 Q1 220 105 M $1.58B
2019 Q4 218 104 M $2.43B
2019 Q3 188 103 M $1.71B
2019 Q2 195 104 M $1.65B
2019 Q1 207 105 M $1.48B
2018 Q4 215 107 M $1.64B
2018 Q3 199 107 M $1.97B
2018 Q2 200 104 M $1.89B
2018 Q1 200 103 M $1.78B
2017 Q4 185 102 M $1.81B
2017 Q3 181 105 M $2.02B
2017 Q2 156 106 M $1.62B
2017 Q1 164 108 M $1.44B
2016 Q4 157 111 M $1.47B
2016 Q3 162 110 M $1.48B
2016 Q2 171 108 M $1.17B
2016 Q1 155 107 M $1.26B
2015 Q4 162 108 M $1.29B
2015 Q3 164 106 M $1.14B
2015 Q2 180 107 M $1.73B
2015 Q1 159 102 M $1.53B
2014 Q4 160 99.0 M $1.44B
2014 Q3 169 95.8 M $1.16B
2014 Q2 167 94.6 M $1.49B
2014 Q1 143 84.7 M $1.06B